The Influence of Methylating Mutations on Acute Myeloid Leukemia: Preliminary Analysis on 56 Patients.

TCGA acute myeloid leukemia classification methylation mutations

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
29 Apr 2020
Historique:
received: 13 04 2020
revised: 26 04 2020
accepted: 28 04 2020
entrez: 6 5 2020
pubmed: 6 5 2020
medline: 6 5 2020
Statut: epublish

Résumé

Acute myeloid leukemia (AML) is a hematologic malignancy characterized by abnormal proliferation and a lack of differentiation of myeloid blasts. Considering the dismal prognosis this disease presents, several efforts have been made to better classify it and offer a tailored treatment to each subtype. This has been formally done by the World Health Organization (WHO) with the AML classification schemes from 2008 and 2016. Nonetheless, there are still mutations that are not currently included in the WHO AML classification, as in the case of some mutations that influence methylation. In this regard, the present study aimed to determine if some of the mutations that influence DNA methylation can be clustered together regarding methylation, expression, and clinical profile. Data from the TCGA LAML cohort were downloaded via cBioPortal. The analysis was performed using R 3.5.2, and the necessary packages for classical statistics, dimensionality reduction, and machine learning. We included only patients that presented mutations in

Identifiants

pubmed: 32365516
pii: diagnostics10050263
doi: 10.3390/diagnostics10050263
pmc: PMC7277399
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Leukemia. 2018 Feb;32(2):295-302
pubmed: 28751771
Genome Biol. 2014;15(12):550
pubmed: 25516281
Science. 2008 Sep 26;321(5897):1807-12
pubmed: 18772396
Leukemia. 1993 Jul;7(7):970-7
pubmed: 8321047
Cancer Cell. 2010 Dec 14;18(6):553-67
pubmed: 21130701
Cold Spring Harb Perspect Med. 2017 May 1;7(5):
pubmed: 28159832
Blood Cancer J. 2016 Jan 15;6:e385
pubmed: 26771811
Int J Hematol. 2016 Jun;103(6):627-33
pubmed: 26980223
Leukemia. 2017 Apr;31(4):798-807
pubmed: 28111462
Bioinformatics. 2015 May 15;31(10):1686-8
pubmed: 25600944
Oncotarget. 2017 Jun 27;8(38):63110-63120
pubmed: 28968975
Leukemia. 2010 Mar;24(3):660-3
pubmed: 20016532
Onco Targets Ther. 2018 Dec 28;12:303-308
pubmed: 30643428
Nat Med. 2018 Dec;24(12):1859-1866
pubmed: 30420752
Nucleic Acids Res. 2002 Feb 15;30(4):958-65
pubmed: 11842107
Cancer Sci. 2018 Feb;109(2):340-353
pubmed: 29220122
N Engl J Med. 2010 Dec 16;363(25):2424-33
pubmed: 21067377
Cell Rep. 2014 Dec 11;9(5):1841-1855
pubmed: 25482556
Blood. 2016 May 19;127(20):2498-501
pubmed: 26968532
N Engl J Med. 2010 Mar 25;362(12):1144-5
pubmed: 20335593
Oncologist. 2013;18(5):619-24
pubmed: 23671007
Nat Rev Dis Primers. 2016 Mar 10;2:16010
pubmed: 27159408
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7517-22
pubmed: 18483194
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Blood. 2018 Sep 6;132(10):1007-1012
pubmed: 30037885
Lancet. 2006 Nov 25;368(9550):1894-907
pubmed: 17126723
Nat Rev Cancer. 2010 Oct;10(10):721-8
pubmed: 20844554
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
Leukemia. 2018 Dec;32(12):2546-2557
pubmed: 30275526
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Neoplasia. 2018 Nov;20(11):1106-1120
pubmed: 30245403
Nat Genet. 2011 Mar 13;43(4):309-15
pubmed: 21399634
Oncotarget. 2017 Oct 16;8(65):108738-108759
pubmed: 29312564
Onco Targets Ther. 2017 Aug 22;10:4143-4151
pubmed: 28860824
Blood. 2019 Feb 14;133(7):676-687
pubmed: 30510081
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Clin Biochem. 2018 Nov;61:34-39
pubmed: 30176240
Nat Med. 2018 Jan;24(1):103-112
pubmed: 29227476
N Engl J Med. 2009 Sep 10;361(11):1058-66
pubmed: 19657110
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
Blood. 2007 Jan 15;109(2):431-48
pubmed: 16960150
Future Oncol. 2018 Apr;14(10):979-993
pubmed: 29543066
J Clin Oncol. 2010 Aug 1;28(22):3636-43
pubmed: 20567020
Blood. 2009 Jul 30;114(5):937-51
pubmed: 19357394
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
J Biol Chem. 2019 Mar 29;294(13):4898-4910
pubmed: 30705090
Mod Pathol. 2015 May;28(5):706-14
pubmed: 25412851
N Engl J Med. 2018 Jun 21;378(25):2386-2398
pubmed: 29860938
Front Pediatr. 2017 Feb 09;5:4
pubmed: 28232907
Cancer Med. 2017 Feb;6(2):349-360
pubmed: 28070990
Leukemia. 2016 Mar;30(3):555-61
pubmed: 26522083
Nat Struct Mol Biol. 2010 Jan;17(1):62-8
pubmed: 20010842
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1196-1202
pubmed: 30779089
Leukemia. 2017 Oct;31(10):2011-2019
pubmed: 28074068
J Exp Med. 2019 Apr 1;216(4):966-981
pubmed: 30890554
Clin Epigenetics. 2019 Mar 15;11(1):50
pubmed: 30876483

Auteurs

Sergiu Pasca (S)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.
Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.

Cristina Turcas (C)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.
Department of Hematology, Ion Chiricuta Clinical Cancer Center, 400006 Cluj Napoca, Romania.

Ancuta Jurj (A)

Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.

Patric Teodorescu (P)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.
Department of Hematology, Ion Chiricuta Clinical Cancer Center, 400006 Cluj Napoca, Romania.

Sabina Iluta (S)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.
Department of Hematology, Ion Chiricuta Clinical Cancer Center, 400006 Cluj Napoca, Romania.

Ionut Hotea (I)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.
Department of Hematology, Ion Chiricuta Clinical Cancer Center, 400006 Cluj Napoca, Romania.

Anca Bojan (A)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.
Department of Hematology, Ion Chiricuta Clinical Cancer Center, 400006 Cluj Napoca, Romania.

Cristina Selicean (C)

Department of Hematology, Ion Chiricuta Clinical Cancer Center, 400006 Cluj Napoca, Romania.

Bogdan Fetica (B)

Department of Hematology, Ion Chiricuta Clinical Cancer Center, 400006 Cluj Napoca, Romania.

Bobe Petrushev (B)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.

Vlad Moisoiu (V)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.

Alina-Andreea Zimta (AA)

Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.

Valentina Sas (V)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.

Catalin Constantinescu (C)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.
Department of Hematology, Ion Chiricuta Clinical Cancer Center, 400006 Cluj Napoca, Romania.

Mihnea Zdrenghea (M)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.
Department of Hematology, Ion Chiricuta Clinical Cancer Center, 400006 Cluj Napoca, Romania.

Delia Dima (D)

Department of Hematology, Ion Chiricuta Clinical Cancer Center, 400006 Cluj Napoca, Romania.

Ciprian Tomuleasa (C)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.
Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400124 Cluj Napoca, Romania.
Department of Hematology, Ion Chiricuta Clinical Cancer Center, 400006 Cluj Napoca, Romania.

Classifications MeSH